Novel approaches to whole sporozoite vaccination against malaria. 2015

Else M Bijker, and Steffen Borrmann, and Stefan H Kappe, and Benjamin Mordmüller, and Brandon K Sack, and Shahid M Khan
Radboud University Medical Center, Department of Medical Microbiology, PO Box 9101, 6500 HB Nijmegen, The Netherlands. Electronic address: else.bijker@radboudumc.nl.

The parasitic disease malaria threatens more than 3 billion people worldwide, resulting in more than 200 million clinical cases and almost 600,000 deaths annually. Vaccines remain crucial for prevention and ultimately eradication of infectious diseases and, for malaria, whole sporozoite based immunization has been shown to be the most effective in experimental settings. In addition to immunization with radiation-attenuated sporozoites, chemoprophylaxis and sporozoites (CPS) is a highly efficient strategy to induce sterile protection in humans. Genetically attenuated parasites (GAP) have demonstrated significant protection in rodent studies, and are now being advanced into clinical testing. This review describes the existing pre-clinical and clinical data on CPS and GAP, discusses recent developments and examines how to transform these immunization approaches into vaccine candidates for clinical development.

UI MeSH Term Description Entries
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D010961 Plasmodium A genus of protozoa that comprise the malaria parasites of mammals. Four species infect humans (although occasional infections with primate malarias may occur). These are PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE, and PLASMODIUM VIVAX. Species causing infection in vertebrates other than man include: PLASMODIUM BERGHEI; PLASMODIUM CHABAUDI; P. vinckei, and PLASMODIUM YOELII in rodents; P. brasilianum, PLASMODIUM CYNOMOLGI; and PLASMODIUM KNOWLESI in monkeys; and PLASMODIUM GALLINACEUM in chickens. Plasmodiums
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D014613 Vaccines, Attenuated Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. Attenuated Vaccine,Vaccines, Live, Attenuated,Attenuated Vaccines,Vaccine, Attenuated

Related Publications

Else M Bijker, and Steffen Borrmann, and Stefan H Kappe, and Benjamin Mordmüller, and Brandon K Sack, and Shahid M Khan
August 2014, Immunologic research,
Else M Bijker, and Steffen Borrmann, and Stefan H Kappe, and Benjamin Mordmüller, and Brandon K Sack, and Shahid M Khan
June 2015, Vaccine,
Else M Bijker, and Steffen Borrmann, and Stefan H Kappe, and Benjamin Mordmüller, and Brandon K Sack, and Shahid M Khan
January 2018, NPJ vaccines,
Else M Bijker, and Steffen Borrmann, and Stefan H Kappe, and Benjamin Mordmüller, and Brandon K Sack, and Shahid M Khan
December 2022, NPJ vaccines,
Else M Bijker, and Steffen Borrmann, and Stefan H Kappe, and Benjamin Mordmüller, and Brandon K Sack, and Shahid M Khan
January 2017, Expert review of vaccines,
Else M Bijker, and Steffen Borrmann, and Stefan H Kappe, and Benjamin Mordmüller, and Brandon K Sack, and Shahid M Khan
May 2012, Trends in immunology,
Else M Bijker, and Steffen Borrmann, and Stefan H Kappe, and Benjamin Mordmüller, and Brandon K Sack, and Shahid M Khan
June 2022, The FEBS journal,
Else M Bijker, and Steffen Borrmann, and Stefan H Kappe, and Benjamin Mordmüller, and Brandon K Sack, and Shahid M Khan
May 1991, Science (New York, N.Y.),
Else M Bijker, and Steffen Borrmann, and Stefan H Kappe, and Benjamin Mordmüller, and Brandon K Sack, and Shahid M Khan
January 1977, Transactions of the Royal Society of Tropical Medicine and Hygiene,
Else M Bijker, and Steffen Borrmann, and Stefan H Kappe, and Benjamin Mordmüller, and Brandon K Sack, and Shahid M Khan
January 2022, Frontiers in immunology,
Copied contents to your clipboard!